CDX-301: Pilot trial started

Celldex began an open-label, U.S. pilot trial to evaluate CDX-301 for 5 or 7 days alone and in combination with Mozobil plerixafor in up to 18 human leukocyte antigen (HLA)-matched donor/recipient s...